EP on EP Episode 52 - Device Detected AF & Stroke Risk-EP on EP Episode 52

Video Transcription

Video Summary

In this episode of EP on EP, Eric Berstowski interviews Dr. Daniel Singer, a professor of medicine at Harvard University, about device-detected atrial fibrillation (AFib). They discuss the evidence regarding stroke risk in patients with subclinical AFib and the role of anticoagulation. They mention studies such as ASSERT-1, ASSERT-2, the TREND study, and the KP Rhythm study, which have provided insights into AFib burden and stroke risk. They also touch on the use of wearables for detecting AFib and the importance of validating such detections with prolonged monitoring. The interview ends with the acknowledgement that more data is needed in this area.

Keywords

device-detected atrial fibrillation

stroke risk

subclinical AFib

anticoagulation

wearables